Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator.

Source:http://linkedlifedata.com/resource/pubmed/id/18163548

J. Med. Chem. 2008 Jan 24 51 2 183-6

Download in:

View as

General Info

PMID
18163548